http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
균기산(勻氣散)이 흰쥐의 국소뇌혈류량 및 평균혈압에 미치는 효과
정종안,홍석,전상윤,Jung, Jong-An,Hong, Seok,Jun, Sang-Yun 대한한의학방제학회 2007 大韓韓醫學方劑學會誌 Vol.15 No.2
Kyungisan (KGS) has been used in oriental medicine for many centuries as a therapeutic agent for treatment of stroke caused by deficiency of qi(氣虛). This study was performed to evaluate effects of KGS extract on the regional cerebral blood flow(rCBF) and mean arterial blood pressure(MABP) in rats. The result of this study were as follow ; 1. KGS significantly increased rCBF irrelevant to MABP in normal rats, 2. To prescribe KGS after pretreatment with indomethacin(IDN) decreased rCBF as compared with control group to administered only KGS in normal rats. But the change of MABP is not significantly as compared with control group. 3. To prescribe KGS after pretreatment with methylen blue( MTB) decreased MABP and rCBF as compared with control group to administered only KGS in normal rats. Especially, it significantly decreased rCBF. These results suggest that KGS increase rCBF by enlargement diameter of pial artery in brain. The active mechanism of KGS is related with prostaglandin activated by cyclooxygenase. So, I suggest that KGS has an anti-ischemic effect through the improvement of cerebral blood flow and can be used for stroke.
정수미,김성진,김방울,전상윤,홍석,김행진,Jung, Soo-Mi,Kim, Sung-Jin,Kim, Bang-Ul,Jun, Sang-Yun,Hong, Seok,Kim, Haeng-Jin 대한한방내과학회 2004 大韓韓方內科學會誌 Vol.25 No.4
This study was designed to analyze the effectiveness of the diagnosis and treatments of hemorrhagic infarction patients in oriental medicine. In this study the clinical symptoms of two hemorrhagic infarction patients improved after diagnosis and treatment of oriental medicine. Though improvement was seen after diagnosis and treatment of both hemorrhagic infarction patients, the early stage of hemorrhagic infarction required western fluid therapy treatments. Study of more cases will be needed in order to varify efficacy for these oriental treatments to be generally applied.
Moya moya disease 환자(患者) 2례(例)에 대한 임상적(臨床的) 고찰(考察)
김행진,이경환,김용진,김방울,전상윤,홍석,노영만,Kim Haeng-Jin,Lee Kyoung-Hwan,Kim Yong-Jin,Kim Bang-Ul,Jun Sang-Yun,Hong Seok,No Young-Man 대한한방내과학회 2003 大韓韓方內科學會誌 Vol.24 No.4
Objectives: This study was designed to analyze the effectiveness of the diagnosis and treatments of Moya moya disease in oriental medicine. Results: This study showed that clinical symptoms of two Moya moya patients were improved by the diagnosis and treatments of oriental medicine. Conclusions: Diagnosis and treatment of two patients with Moya moya disease are accurate and effective. However, more cases are required to study in oriental medicine in order to prove the availability and to be applied universally.
소목(蘇木)이 산화적 손상 및 Raw 264.7 cell과 HUVEC에서의 염증 유관 인자에 미치는 영향
강성순,김명신,조재준,최성안,양의호,전상윤,최창원,홍석,Kang, Seong-Sun,Kim, Myung-Sin,Jo, Jae-Jun,Choi, Seong-An,Yang, Eui-Ho,Jeon, Sang-Yun,Choi, Chang-Won,Hong, Soek 대한한방내과학회 2013 大韓韓方內科學會誌 Vol.34 No.1
Objectives : This study investigated the impact of Caesalpinia sappan L. on oxidative damage and inflammatory relevant factor in RAW 264.7 cells and human umbilical vein endothelial cells (HUVEC). Methods : We determined whether fractionated EtOH extracts of Caesalpinia sappan L. (CSL) inhibit free radical generation such as 2,2-diphenyl-1-picrylhydrazyl (DPPH), reactive oxygen species (ROS) and nitric oxide (NO) and pro-inflammatory cytokines in lipopolysaccharide (LPS)-treated RAW 264.7 cells and HUVEC. Result : 1. DPPH removal capacity was increased by CSL. 2. LPS-induced ROS, and NO inhibitory capacity were increased by CSL. 3. LPS-induced cell death of Raw 264.7 cells was decreased by CSL. 4. The amount of cytokine generation in Raw 264.7 cell was decreased significantly by CSL. 5. The amount of cytokine generation in HUVEC was decreased significantly by CSL. Conclusions : These results suggest that CSL supplement may attenuate oxidative stress by elevated antioxidative processes, and suppress inflammatory mediator activation.